Malaria is a major health problem causing over 212 million clinical cases every year around
the world. In Indonesia, Timika is one of the highest malaria-endemic areas with a high …

Background High parasite-specific antibody levels are generally associated with low
susceptibility to Plasmodium falciparum malaria. This has been supported by several studies …

Background The Plasmodium vivax Duffy Binding Protein (PvDBP) is a key target of
naturally acquired immunity. However, region II of PvDBP, which contains the receptor …

HIV infected individuals in malaria endemic areas experience more frequent and severe
malaria episodes compared to non HIV infected. This clinical observation has been linked to …

Asymptomatic Plasmodium falciparum infection is responsible for maintaining malarial
disease within human populations in low transmission countries such as Haiti. Investigating …

Malaria is the most prevalent infectious disease in the world today, in regard to morbidity
and mortality, and it is mostly affecting sub Saharan Africa. High priority is put on the …

Plasmodium falciparum infections elicit strong humoral immune responses to two main
groups of antigens expressed by blood-stage parasites: merozoite antigens that are …

Memory B cells (MBCs) and plasma antibodies against Plasmodium falciparum (Pf)
merozoite antigens are important components of the protective immune response against …

Memory B cells (MBCs) and plasma antibodies against Plasmodium falciparum merozoite
antigens are important components of the protective immune response against malaria. To …

Memory B cells and plasma antibodies against Plasmodium falciparum merozoite antigens
are important components of the protective immune response against malaria. In-depth …